JP2023538521A5 - - Google Patents
Info
- Publication number
- JP2023538521A5 JP2023538521A5 JP2023507887A JP2023507887A JP2023538521A5 JP 2023538521 A5 JP2023538521 A5 JP 2023538521A5 JP 2023507887 A JP2023507887 A JP 2023507887A JP 2023507887 A JP2023507887 A JP 2023507887A JP 2023538521 A5 JP2023538521 A5 JP 2023538521A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- substituted
- group
- pharmaceutically acceptable
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063063113P | 2020-08-07 | 2020-08-07 | |
| US63/063,113 | 2020-08-07 | ||
| PCT/US2021/044907 WO2022032071A1 (en) | 2020-08-07 | 2021-08-06 | Kinase inhibitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538521A JP2023538521A (ja) | 2023-09-08 |
| JP2023538521A5 true JP2023538521A5 (https=) | 2024-08-15 |
Family
ID=77711412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507887A Pending JP2023538521A (ja) | 2020-08-07 | 2021-08-06 | キナーゼ阻害剤およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230303570A1 (https=) |
| EP (1) | EP4192582A1 (https=) |
| JP (1) | JP2023538521A (https=) |
| KR (1) | KR20230112605A (https=) |
| CN (1) | CN116710453A (https=) |
| AU (1) | AU2021321536A1 (https=) |
| BR (1) | BR112023002248A2 (https=) |
| CA (1) | CA3179671A1 (https=) |
| MX (1) | MX2023001312A (https=) |
| WO (1) | WO2022032071A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4577546A1 (en) * | 2022-08-25 | 2025-07-02 | Enliven Inc. | Naphthyridine compounds for inhibition of raf kinases |
| WO2024199388A1 (zh) * | 2023-03-29 | 2024-10-03 | 微境生物医药科技(上海)有限公司 | 作为myt1抑制剂的化合物 |
| WO2025064567A1 (en) * | 2023-09-19 | 2025-03-27 | Enliven Inc. | Tricyclic phenols for inhibition of raf kinases |
| WO2025152919A1 (en) * | 2024-01-15 | 2025-07-24 | Impact Therapeutics (Shanghai) , Inc. | Crystal forms of a weel inhibitor and preparation method thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006503802A (ja) * | 2002-04-03 | 2006-02-02 | エフ．ホフマン−ラ ロシュ アーゲー | イミダゾ縮合化合物 |
| EP2348020A1 (en) | 2009-12-23 | 2011-07-27 | Esteve Química, S.A. | Preparation process of erlotinib |
| FR2974088A1 (fr) * | 2011-04-12 | 2012-10-19 | Pf Medicament | Composes pyrazolo[3,4-b]pyridines tri- et tetracycliques comme agent anticancereux |
| RU2019102647A (ru) * | 2016-07-01 | 2020-08-03 | Г1 Терапьютикс, Инк. | Антипролиферационные средства на основе пиримидина |
| EP3684772B1 (en) * | 2017-09-20 | 2023-12-06 | ABM Therapeutics Corporation | Cyclic iminopyrimidine derivatives as kinase inhibitors |
| CN110950867A (zh) * | 2018-09-27 | 2020-04-03 | 首药控股(北京)有限公司 | 一种fgfr4激酶抑制剂及其制备方法和用途 |
-
2021
- 2021-08-06 KR KR1020237007882A patent/KR20230112605A/ko active Pending
- 2021-08-06 US US18/019,377 patent/US20230303570A1/en active Pending
- 2021-08-06 MX MX2023001312A patent/MX2023001312A/es unknown
- 2021-08-06 EP EP21769214.4A patent/EP4192582A1/en active Pending
- 2021-08-06 WO PCT/US2021/044907 patent/WO2022032071A1/en not_active Ceased
- 2021-08-06 BR BR112023002248A patent/BR112023002248A2/pt unknown
- 2021-08-06 JP JP2023507887A patent/JP2023538521A/ja active Pending
- 2021-08-06 AU AU2021321536A patent/AU2021321536A1/en active Pending
- 2021-08-06 CA CA3179671A patent/CA3179671A1/en active Pending
- 2021-08-06 CN CN202180068725.2A patent/CN116710453A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538521A5 (https=) | ||
| JP7057798B2 (ja) | ｍＴＯＲＣ１阻害剤 | |
| CN1642542B (zh) | 血管新生抑制剂 | |
| JP7394768B2 (ja) | キナーゼ阻害剤としての環状イミノピリミジン誘導体 | |
| JP2018533611A5 (https=) | ||
| US10759803B2 (en) | Asparagine endopeptidase (AEP) inhibitors for managing cancer and compositions related thereto | |
| RU2016118753A (ru) | Производные пиридилкетона, способ их получения и их фармацевтическое применение | |
| JP2010539095A5 (https=) | ||
| JPWO2008001886A1 (ja) | オーロラ（Ａｕｒｏｒａ）阻害剤 | |
| WO2013173254A1 (en) | Bicyclic compounds as kinases inhibitors | |
| JP2014518544A5 (https=) | ||
| WO2012000421A1 (zh) | 棉酚衍生物在制备抗肿瘤药物中的应用 | |
| JP2015515995A (ja) | キナーゼ阻害剤として有用な置換アミノキナゾリン | |
| JP4707393B2 (ja) | 抗癌化合物 | |
| CN110078730B (zh) | 作为pi3k/mtor抑制剂的喹啉取代的稠合喹啉化合物 | |
| CA3130471A1 (en) | Pan-raf kinase inhibitor and use thereof | |
| JP5701387B2 (ja) | ベルバミンのジカルボキシミド誘導体、その調製方法及び使用 | |
| JP2016522223A (ja) | チロシンキナーゼ阻害活性を有する物質ならびにその調製方法および使用 | |
| WO2017180723A1 (en) | Ataxia telengiectasia and rad3-related (atr) inhibitors and methods of their use | |
| AU2015355965B2 (en) | Novel PEG derivative | |
| JP5794873B2 (ja) | 抗腫瘍剤 | |
| JP2013510899A5 (https=) | ||
| US12036215B2 (en) | Antitumor agent and method for tumor therapy | |
| CN111039940A (zh) | 一种Aurora A激酶抑制剂、制备方法、药物组合物及其用途 | |
| CN112442062A (zh) | 一种柳胺酚有机硅化合物及抗肿瘤用途 |